SEP 4, 2026 · JOURNAL ARTICLE
Associations of baseline [18F]FDG PET/CT metabolic parameters with the efficacy of neoadjuvant immunotherapy plus concurrent chemoradiotherapy in patients with locally advanced gastric adenocarcinoma: a post hoc analysis of the Neo-PLANET phase II trial
BMC Medical Imaging
Post hoc analysis of a phase II trial with small sample (n=29) and surrogate/exploratory endpoints; findings are hypothesis-generating and require validation in larger populations.
Reported
Sample size29
S-SUVmean and DFS hazard ratio0.19
S-SUVmean and DFS 95% CI0.037–0.94